Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice - Wikidata - awgldk - TriplyDB

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

http://www.wikidata.org/entity/Q30490333

about

Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling Sphingolipid signaling in metabolic disorders Biomechanical factors and macrophages in plaque stability All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity Functional characterization of enzymes catalyzing ceramide phosphoethanolamine biosynthesis in mice Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis Increased intestinal lipid absorption caused by Ire1β deficiency contributes to hyperlipidemia and atherosclerosis in apolipoprotein E-deficient mice.Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.Pharmacologic inhibition of sphingomyelin synthase (SMS) activity reduces apolipoprotein-B secretion from hepatocytes and attenuates endotoxin-mediated macrophage inflammation.Ceramide is involved in alcohol-induced neural proliferation.Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.Reducing plasma membrane sphingomyelin increases insulin sensitivity.Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice.Disturbed flow induces systemic changes in metabolites in mouse plasma: a metabolomics study using ApoE⁻/⁻ mice with partial carotid ligation.Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans.Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system.Sphingolipid metabolism and obesity-induced inflammation.Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.Degradation and beyond: the macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis.The vicious circle between oxidative stress and inflammation in atherosclerosis.Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.Molecular biology of atherosclerosis.The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.Identification of Key Genes Affecting Results of Hyperthermia in Osteosarcoma Based on Integrative ChIP-Seq/TargetScan Analysis.SMS regulates the expression and function of P-gp and MRP2 in Caco-2 cells.Sphingomyelin Synthase 1 Regulates Neuro-2a Cell Proliferation and Cell Cycle Progression Through Modulation of p27 Expression and Akt Signaling.Sphingolipids and Lipoproteins in Health and Metabolic Disorders.Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells.Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthases.Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthases.Development, Validation, and Application of a Novel Method for Mammalian Sphingomyelin Synthase Activity Measurement Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis Contribution of p62/SQSTM1 to PDGF-BB-induced myofibroblast-like phenotypic transition in vascular smooth muscle cells lacking Smpd1 gene

P2860

Q26866939-F398AFB9-E1DB-44A5-B633-F223C349DBA7 Q26992148-508A52ED-40CB-466B-8D34-D3353E09B9CD Q27693877-7C0119BD-0720-4417-BA29-7F3C9E5A2C24 Q28117543-D0D02226-1F4D-48EB-B45F-39DD136D5D7B Q28506403-EE667F90-B511-49CF-B3F6-E401B3801A9C Q30433021-9A5DAEC3-1978-47F6-AB6F-BC10396A4724 Q30518782-BF89B561-BB55-4908-AEEB-EE019FE67F43 Q30524346-1CA3AB3A-62EB-4273-BB55-89EE4F0CBA78 Q33916433-DC64439B-4C73-419E-8082-839D2B485DBF Q34095500-5293FD29-9648-4456-BF29-0D304C2636FA Q34116322-5B1DC4F5-0476-4738-AB59-3751983C7733 Q34208250-5C33FC96-78DE-43B9-A600-3E70BB2B449F Q34412400-522457C0-B481-4C3E-94F6-C51EE9857E6D Q34674948-8D3F842A-1B31-4916-9ED4-A18C7F935155 Q34800887-D8FC2724-DA82-4F5A-B174-92EE3B6FC798 Q35035234-DCDC826B-B203-4708-ADC5-0ADA0776EC96 Q35150259-62A4CB70-9ED7-4F1A-9AE9-EFF4F99B868E Q35324757-C585D335-4916-4A60-9A10-C32BE6440975 Q36239748-B901CE34-740C-469E-85C6-6CD50DD6615A Q36774954-8955AB20-54A6-4D65-8326-4A7C1D5DDA29 Q36898608-2D84959B-A93B-40C3-BABD-0B3ED365D67B Q37200535-57FC08E8-F68C-46D0-ACE3-861D8531798B Q37265183-2E87585A-D5E0-462D-A71B-FC4F71914D40 Q37334949-24AE21C7-18C6-484B-A6E1-63FEECE0F623 Q37498720-314A9D6B-B078-45D5-8110-D09A51C29575 Q37673848-EEA406D1-F29E-4E7E-ACEB-2F84D83AEC2A Q38125279-2E265CDD-FA47-4252-8899-F46A5E99BD27 Q38244084-69AA7424-5174-49C3-A7B3-C3C9B7E9505E Q38434174-1B035D94-619B-4AB3-9CB1-50D96CC35457 Q38759057-A7AEB50C-5049-4096-8693-DC4ACD5C2FB5 Q38969493-4CC90059-FD86-4BFD-B455-E3F0836D1E3F Q39277798-F4B8F9CB-6CC0-4228-A113-CF700D2B5B2C Q39573995-2E01A714-476D-4CC6-A89C-F885CF2368AA Q41863719-9AA99C7A-4483-4E2E-A82A-850BD2DAB976 Q42507138-3056F17D-07B1-46FE-B766-29E0EE4874D1 Q47170906-52F7D441-9FAD-4262-BC63-0C6E0308B700 Q50948168-FEA69A81-90DA-47B2-B1D6-B81294D064B7 Q58183400-C40A5D5F-A5A1-433E-9DF4-EC96C35E042E Q58730164-5131CD68-166B-4407-9EA7-EA4BD0210E72 Q59126374-E691C7C8-7394-470D-82CB-1D2974056818

P2860

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

http://www.wikidata.org/entity/Q30490333

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@ast

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@en

type

label

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@ast

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@en

prefLabel

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@ast

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@en

P1433

Q30490333-8031F601-BDE2-417F-9687-8159E4D09DCD

P1476

Q30490333-66265400-8574-4D77-9CB8-285D67160723

P2093

Q30490333-19B043C7-625C-459C-B896-CB65D5F9CC9D

Q30490333-29EF4971-120C-4DC4-B8CD-B6E2A95C2D92

Q30490333-44F49EB7-1D66-41D1-94D0-4597815CC2D5

Q30490333-47AC6DC7-18F4-46FC-9B1A-0E9E099988D4

Q30490333-640D9425-5E00-4FB8-9D8E-D6A9E0405AF5

Q30490333-A2BD0289-F614-4048-BBFC-17BA33E6FC72

Q30490333-ABE3B2F5-75EE-485A-A995-89CD2C384D0A

Q30490333-BB8F01CF-5FE4-4E4D-AD8C-4A28D4E7B858

P2860

Q30490333-02E12538-85CD-426E-BF2A-37B29700F823

Q30490333-02F97AD2-4A52-4B7E-A6AF-EE55A7A5E48A

Q30490333-0B29F5AA-6CE4-4432-926E-AE1037E11E7F

Q30490333-1B49F093-D618-48E5-9F37-D73250C75A0A

Q30490333-1C908FE0-2876-4B6A-A617-2587FE235E7F

Q30490333-1F2C10C6-C0DD-40B1-9E27-DE473E1AA97C

Q30490333-2249D757-BD8F-4240-8E0F-B7D0C7E380E9

Q30490333-25D49404-3DB2-4778-B804-02E3FBA7779C

Q30490333-298317F8-501F-4A7C-913E-D3AAB79B4AB4

Q30490333-2D15225F-086B-4507-8A1A-81DFACEF5511

P304

Q30490333-B3CB7A19-4146-4C96-8AB8-9EF3CF1560C6

P31

Q30490333-D2E6A50C-5313-407E-BB22-4DE82C35DED0

P356

Q30490333-1CFDFC9E-57B3-4358-8DDC-FFA676EA60EA

P433

Q30490333-7F38D9E3-4210-4DAC-ADC5-E066E5B7F378

P478

Q30490333-A22402DF-38AF-4BB4-8416-26DB40B93370

P577

Q30490333-FD7F75C7-3C0F-4A0C-A812-D83F6DDAEFB3

P5875

Q30490333-CE92642B-6952-4656-A9EC-3956944B3B9E

P698

Q30490333-027EA213-76B9-4AB0-971D-2E0B7FC19C31

P921

Q30490333-7807DC03-259E-4BC1-9250-AF09861F6B5D

Q30490333-8F071FCA-31F9-452E-8B83-99A95F7A58D5

P932

Q30490333-AFF8E951-A9B9-4FF0-B57D-5E54C7C681C4

P356

CIRCRESAHA.109.194613

P1433

Circulation Research

P1476

Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice

@en

P2093

Chongmin Huan

http://www.w3.org/2001/XMLSchema#string

Da Lu

http://www.w3.org/2001/XMLSchema#string

Guoqing Cao

http://www.w3.org/2001/XMLSchema#string

Hongqi Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Mahua Chakraborty

http://www.w3.org/2001/XMLSchema#string

Ming-Shang Kuo

http://www.w3.org/2001/XMLSchema#string

Xian-Cheng Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a family of animal sphingomyelin synthases.

LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL

Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells

Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization

Functional rafts in cell membranes

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

Inflammation in atherosclerosis

The pathogenesis of atherosclerosis: a perspective for the 1990s

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

Structure and function of sphingolipid- and cholesterol-rich membrane rafts

P304

295-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.109.194613

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26659137

http://www.w3.org/2001/XMLSchema#string

P698

19590047

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2746935

http://www.w3.org/2001/XMLSchema#string